Diageo-controlled liquor maker United Spirits Ltd (USL) on Wednesday reported a 20.82 per cent rise in consolidated net profit at Rs 280.3 crore for the third quarter ended December 2020. The company's board, on Wednesday, also approved the succession plan to appoint Hina Nagarajan as the Chief Executive Officer – Designate of the company from April 1.
USL had posted a net profit of Rs 232 crore in the 2019 December quarter. The company's revenues from operations jumped 7.65 per cent to Rs 8,410.3 crore in the latest December quarter. In the year-ago period, the same stood at Rs 7,812.3 crore, according to a regulatory filing.
However, total expenses climbed to Rs 8,074.5 crore in the third quarter of the current fiscal as against Rs 7,503.3 crore in the same period a year ago. "Operational resilience, contextual marketing with focus on in-home occasions and renovation of our core brands supported the top-line recovery," Diageo India MD & CEO Anand Kripalu said.
The third quarter reflects improving consumer sentiment over previous quarters, notwithstanding on-premise footfalls still being low, the route to market change in Andhra Pradesh and taxation led price hikes post COVID-19, he added. Its Prestige and above segment net sales moderately declined in the latest December quarter, albeit lapping strong normal festive base comparatives while performance of Scotch portfolio continued to be encouraging.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
"The third quarter witnessed benign commodities which, along with continued productivity, facilitated marginal expansion of gross margin to 44.6 per cent," he said. Kripalu said that despite a quicker rebound than originally expected in the near term, there are still reasons to remain cautious and consequently, it was not providing quantitative guidance for fiscal 2021.
"Our business continues to exhibit strong fundamentals and our focus to 'Emerge stronger' will hold us in good stead," he said. As per USL's succession plan, Nagarajan would work closely work withKripalu up to June 30, 2021.
Thereafter, Kripalu will step down as the Managing Director & Chief Executive Officer and cease to have board responsibilities. "Effective July 1, 2021, Hina Nagarajan will assume office as the new Managing Director & Chief Executive Officer of the company in accordance with the applicable law and upon receipt of necessary approvals," it said.
Nagarajan, who had joined Diageo in the summer of 2018, is currently the Managing Director, Africa Regional Markets (ARM) of Diageo. Prior to that, she had spent over 30 years in Consumer Packaged Goods (CPG) businesses and held several senior positions at Reckitt Benckiser (RB), Nestle India and Mary Kay India.On Wednesday, shares of USL gained 1.60 per cent to close at Rs 644.75 on the BSE.